Non-Executive Chair, Integra LifeSciences Holdings Corporation Independent Director Age: 64 Director since: July 2017 Committees: Finance (Chair) Governance and Corporate Responsibility Other current public company director service: + Integra LifeSciences Holdings Corporation (since 1997) (Non-Executive Chair, June 2012 Feb. 2024; since July 2025) (Executive Chair Jan. 2012 June 2012; Feb. 2024 June 2025) + Piper Sandler Companies (since Feb. 2026) Former public company director service: + Orthofix Medical Inc. (2023 2024) + Owens & Minor, Inc. (2013 2019) + SeaSpine Holdings Corporation (2015 2023) (Lead Director 2015 2023) + St. Jude Medical, Inc. (1999 2017) + Vital Signs, Inc. (1998 2002) + Zimmer Biomet Holdings, Inc. (2005 2008) Experience Integra LifeSciences Holdings Corporation + Non-Executive Chair of Board of Directors (June 2012 February 2024; since July 2025) + Executive Chair of Board of Directors (January 2012 June 2012; February 2024 June 2025) + Chief Executive Officer (1997 2012) Prettybrook Partners LLC + Managing Director (since 2012) Wellington Partners Advisory AG + Venture Partner (since 2013) TowerBrook Capital Partners + Senior Advisor (2010 2025) Goldman, Sachs and Co. + Managing Director, M&A, specializing in the medical device, pharmaceutical and biotechnology sectors (1987 1997) Qualifications + Executive Leadership: Extensive executive management experience and deep strategic expertise in the global healthcare industry gained from over twenty-five years of experience in developing, executing and overseeing the corporate strategy of Integra LifeSciences Holdings Corporation, a manufacturer of medical devices used in neurosurgery and orthopedic surgery, as its Chief Executive Officer for fifteen years and board chair since 2012, during which time revenues increased by over a hundredfold. + Corporate Strategy: Substantial experience in developing, assessing, executing and overseeing corporate strategy in the global healthcare industry acquired over the course of his career in various roles, including through his tenure as the Chief Executive Officer of Integra LifeSciences and significant outside board service, as well as his investment banking, venture capital and private equity firm experiences. + Corporate Finance: Deep knowledge of capital markets, investment banking, and mergers and acquisitions acquired throughout the course of his career in investment banking, during which he specialized in the medical device, pharmaceutical and biotechnology sectors, and applied throughout his career at Integra LifeSciences and his outside board service. + Dr. Essig also brings significant corporate governance, innovation and R&D, human capital management, financial acumen, international business, operations and risk oversight skills and experience to the Board. Education + BA, School of Public and International Affairs at Princeton University + MBA, University of Chicago + PhD, Financial Economics, University of Chicago